<DOC>
	<DOCNO>NCT02071316</DOCNO>
	<brief_summary>The purpose study conduct randomize control trial , double-blind study compare Hexacapron standard care treatment standard care alone evaluate efficacy add effect Hexacapron standard therapy decrease episode rebleeding mortality patient upper gastrointestinal bleeding .</brief_summary>
	<brief_title>The Use Hexacapron Upper Gastrointestinal Bleeding</brief_title>
	<detailed_description>Research Objectives To evaluate efficacy use hexacapron treatment upper gastrointestinal bleed - Primary outcome : Prevention rebleeding manifest hematemesis , melena drop hemoglobin level 2g % within 24 hour therapeutic endoscopy - Secondary outcome : rebleeding , need surgery , 30 day mortality Expected Significance- The sample size need detect 10 % absolute difference proportion rebleeding , drop hemoglobin 2g % hexacapron treat group standard care group group 80 % power 0.05 significant level ( alpha ) . Research method : - Prospective , randomize control trial , double blind , single center - Duration : 2 year - ~ 300≤ participant ,18≤ year age - Patients 18≤ year age admit emergency department Shaare Zedek Medical Center clinical sign symptom upper gastrointestinal bleeding receive initial resuscitation stabilization maintain blood pressure intravascular volume . Patients randomize 3 group : 1 . Treatment group - receive I.V . Esomeprazole 80 mg 8mg/h continuously concurrent hexacapron I.V . every 6 hour 72 hour patient continue oral treatment 6 g /day 7 day . 2 . Standard care group - receive I.V . Esomeprazole 80 mg 8mg/h continuously - Every patient undergo upper endoscopy within 12 hour admission emergency department receive treatment accord endoscopic finding - If reason bleed find upper endoscopy , treatment stop patient exclude - Every participant fill questionnaire inform consent sign . - If sign due medical condition disability guardian sign first degree relative Study population : Patients 18≤ year age admit emergency department Shaare Zedek MedicalCenter clinical sign symptom upper gastrointestinal bleeding include hematemesis , melena drop hemoglobin level 2g % Included : - Patients 18≤ year age admit emergency department Shaare Zedek Medical Center clinical sign , symptom laboratory upper gastrointestinal bleeding - Hospitalized patient Shaare Zedek Medical Center clinical sign , symptom laboratory upper gastrointestinal bleeding • Patients , guardian family member sign inform consent Excluded : - Pregnancy , lactation - History thromboembolic event - Allergic reaction drug - Lower gastrointestinal bleeding - Patient receive anticoagulation treatment - Receive drug interaction hexacapron</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Gastrointestinal Hemorrhage</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients 18≤ year age admit emergency department Shaare Zedek MedicalCenter clinical sign , symptom laboratory upper gastrointestinal bleeding Hospitalized patient Shaare Zedek Medical Center clinical sign , symptom laboratory upper gastrointestinal bleeding Patients , guardian family member sign inform consent Pregnancy , lactation History thromboembolic event Allergic reaction drug Lower gastrointestinal bleed Patient receive anticoagulation treatment Receive drug interaction hexacapron</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>upper gastrointestinal bleeding</keyword>
	<keyword>Hexacapron</keyword>
	<keyword>hemostasis</keyword>
</DOC>